EORTC-24941-HNCG

A randomized phase III study of supportive care plus Methotrexate versus supportive care only in patients with metastatic or recurrent squamous cell carcinoma of the head and neck
Trial StatusAll trial activities ended
DatesDate of activation: 15-May-96
Closed on : 15-Sep-97
Data management at EORTCFull
Phase3
Randomized trialYes
TypeAdvanced
Targeted Sample size200
Number of steps1
Drug
Study Staff
Type of cancerHead and Neck
Participating GroupsEORTC Head and Neck Cancer Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT number
EudraCT
@
Back to Protocol section